SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,403,000 | +197.9% | 148,502 | +182.7% | 0.09% | +172.7% |
| Q2 2020 | $471,000 | +375.8% | 52,527 | +405.5% | 0.03% | +371.4% |
| Q1 2019 | $99,000 | -88.4% | 10,392 | -86.1% | 0.01% | -87.0% |
| Q4 2018 | $857,000 | +62.0% | 74,673 | +168.0% | 0.05% | +45.9% |
| Q1 2018 | $529,000 | +25.1% | 27,862 | +8.0% | 0.04% | -19.6% |
| Q4 2017 | $423,000 | -41.7% | 25,790 | -68.7% | 0.05% | -76.9% |
| Q2 2017 | $726,000 | +881.1% | 82,478 | +417.0% | 0.20% | +1070.6% |
| Q3 2016 | $74,000 | -66.7% | 15,952 | -56.5% | 0.02% | -34.6% |
| Q1 2016 | $222,000 | -60.8% | 36,687 | +1.6% | 0.03% | -55.2% |
| Q1 2015 | $566,000 | -55.7% | 36,100 | -57.0% | 0.06% | -74.3% |
| Q4 2014 | $1,277,000 | – | 83,958 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |